Longevity by Design

InsideTracker
undefined
Nov 11, 2026 • 54min

EP #2: "Cancer Is a Disease of Mistakes" — Derek Chiang on AI, Personalized Medicine, and the Limits of Machine Learning

In this episode of Longevity by Design, host Renée Deehan, VP of Science & Artificial Intelligence is joined by co-host Will Dzierson, VP of Product & Design, both at InsideTracker to welcome the guest Derek Chiang, VP and Head of Computational Biology at Bayer Pharmaceuticals. Renée and Derek — former Berkeley classmates — reconnect to trace how the field of computational biology has evolved from data-starved beginnings into today's AI-driven drug discovery engine. Derek walks through what personalized medicine actually means at a molecular level, using cancer as a case study for how genomic "mistakes" can be matched to targeted therapies.
undefined
Oct 23, 2026 • 50min

LBD 2.0 EP #1: Why Scientific Validity Isn't Enough

In this episode of Longevity by Design, host Renée Deehan, Senior VP of Science, AI & Product, is joined by Will Dzierson, VP of Product & Design, both with InsideTracker, to welcome Ohad Manor, VP of Computational and Precision Health at Thorne. Ohad brings a rare perspective, having traversed academic computational biology, personalized wellness at Arivale, cancer therapeutics and diagnostics, and now consumer precision health at Thorne. The thread connecting all of it: using computation to translate complex biology into something genuinely useful for people.
undefined
Mar 30, 2026 • 1h 10min

Do Longevity Supplements Really Work?

Dr. Andrea Maier, Professor in Medicine and director of NUS’s Healthy Longevity academy, runs human trials and audits supplement quality. She discusses who truly benefits from multivitamins, the “test, then treat” precision approach, widespread label and quality problems with NMN and urolithin, and practical wearable and strength measures to track results over time.
undefined
Mar 28, 2026 • 1h 5min

What Houses, Garbage, and Trucks Teach Us About Aging with Dr. Uri Alon

Dr. Uri Alon, systems biology professor at the Weizmann Institute known for network motifs, shares a simple engineering view of aging. He uses the houses, garbage, and trucks model to frame damage, cleanup, and thresholds. Short takes cover why systems thinking matters, how interventions like senolytics or reprogramming differ, and which biological nodes and experiments reveal aging mechanisms.
undefined
5 snips
Mar 26, 2026 • 1h 2min

Born to Live Longer? Inside the Genetics and Biology of Centenarians

Paola Sebastiani, Professor of Biostatistics at Tufts who studies genetic, proteomic, and metabolomic signatures of exceptional longevity. She explains why there is no single longevity gene and why many small genetic effects matter. They cover APOE, limits of polygenic prediction, low inflammation and metabolite signals in centenarians, diet patterns, and why offspring often inherit protection.
undefined
Mar 18, 2026 • 1h 4min

Age Faster or Slower? The Surprising Role of Mental Health and Self-Control

Dr. Terrie Moffitt, University Professor known for leading the Dunedin longitudinal study linking early-life mental health and self-control to lifelong outcomes. She discusses how people show different biological aging rates, how the Dunedin study measures pace of aging with biomarkers, and why early mental-health and self-control shape health, relationships, and economic outcomes decades later.
undefined
Mar 4, 2026 • 1h 10min

Why Most Longevity Advice Gets Weight and Exercise Wrong

Dr. David Allison, director at Baylor’s USDA Children’s Nutrition Research Center and an authority on rigor in obesity science, challenges common beliefs about weight and exercise. He discusses why reproducible evidence and clear communication matter. Topics include the dentistry model of weight management, limits of exercise for lifespan, translating animal findings to humans, protein intake, and when nutrition claims are overhyped.
undefined
Feb 18, 2026 • 53min

Can Psychedelic Mushrooms Slow Aging?

Dr. Louise Hecker, Associate Professor of Medicine at Baylor College of Medicine, studies aging and tissue repair and probes psilocybin’s biology. She describes lab work showing psilocybin-related effects on cellular lifespan and aging markers. The conversation covers how the mouse longevity study was designed, regulatory hurdles for psychedelic research, and challenges in translating doses and safety to humans.
undefined
Feb 4, 2026 • 1h 5min

Engineering Healthspan with Dr. Nathan Price: Is It Finally Possible?

In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Nathan Price, Professor and Co-Director at the Buck Institute for Research on Aging. Together, they explore how systems biology, artificial intelligence, and deep health data are changing the way we approach aging and prevention. Nathan explains why looking at single biomarkers falls short and why a network view of biology gives a clearer path to understanding disease and resilience.Nathan shares how new tools, like genetics, proteomics, and the emerging field of digital twins, can help predict disease risk years in advance and guide more effective, personalized interventions. He also discusses how integrating data from wearables, blood tests, and the microbiome can help people move from reactive medicine to proactive health decisions, allowing for interventions that fit the individual.The conversation highlights the promise and practical limits of current technologies, the trade-offs involved in optimizing health, and the power of AI to accelerate both research and personal health journeys. Nathan makes a strong case for the unique biology each person brings to the table and shows how the tools available today can help anyone take charge of their own healthspan in ways not possible before.Guest-at-a-Glance💡 Name: Nathan Price💡 What he does: Professor and Co-Director of the Center for Human Healthspan💡 Company: Buck Institute for Research on Aging💡 Noteworthy: Known for advancing systems biology and using AI and multi-omics to personalize health and healthspan interventions.💡 Where to find him: https://www.linkedin.com/in/nathandprice Episode highlights:[00:00:00]: Introduction[00:00:49]: Overview of Systems Biology and Its Role in Health[00:03:23]: Systems Biology vs. Reductionist Approaches[00:04:28]: Systems Biology and the Shift from Treatment to Prevention[00:06:29]: Defining Scientific Wellness[00:08:52]: Early Detection of Disease with Omics and AI[00:12:03]: Genetics and Early Risk Prediction[00:15:18]: Polygenic Risk Scores and Population Diversity[00:17:05]: Explaining Polygenic Risk Scores and Their Applications[00:19:01]: Genetics, Lifestyle Interventions, and LDL Cholesterol[00:20:51]: Integrating Multi-Omics Data for Personalized Health[00:23:15]: AI Revolution in Health Data Analysis[00:24:06]: Personalized Health Guidance and AI Agents[00:27:15]: Scaling Scientific Discovery with AI[00:32:23]: AI’s Impact on Healthspan and Personalized Recommendations[00:34:47]: Human-AI Collaboration and Current Limitations[00:36:23]: Accelerating Health Innovation and the Adjacent Possible[00:38:36]: N-of-1 Experiments and Individualized Health Insights[00:40:25]: Aggregating N-of-1 Data and Community Science[00:42:54]: Digital Twins: Building Personalized Biological Models[00:45:05]: Aging as a Network-Level Phenomenon[00:49:43]: Trade-Offs in Aging and Optimizing Health Behaviors[00:52:01]: Accessibility and Adoption of Omics Technologies[00:55:39]: Pyramid of Health Data: From Dense Omics to Passive Measures[00:59:28]: Rapid-Fire Questions and Key TakeawaysFor science-backed ways to live a healthier, longer life, download InsideTracker's Top 5 biomarkers for longevity eBook at insidetracker.com/podcastConnect with Gil on LinkedIn, Instagram, X
undefined
14 snips
Jan 21, 2026 • 1h 18min

How AI Is Redesigning Longevity | Systems Thinking with Dr. Ronjon Nag

Dr. Ronjon Nag, an Adjunct Professor at Stanford and an expert in AI and genetics, dives into how AI is revolutionizing longevity science. He emphasizes the importance of systems thinking to understand aging as a complex dynamic rather than simple fixes. The discussion includes how integrating diverse health data and AI tools can personalize medical insights and improve decision-making. Ronjon also predicts AI's role in drug discovery and health advancements, while tackling the ethical challenges and limitations that come with this technology.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app